FFTY

Fund Description
Innovator IBD 50 ETF is an exchange-traded fund actively managed and will generally hold all of the companies included in the IBD 50 Index other than during periods when the Fund is rebalanced due to changes in the constitution of the IBD 50 Index. The Fund will not invest in the IBD 50 Index companies in the same proportion as reflected in the Index. Innovator IBD 50 ETF invests in the Top 50 growth stocks as selected by IBD.
Fund Profile
Fund Name Innovator IBD 50 ETF
Fund Exchange Ticker FFTY
Fund Sponsor Innovator Management
Fund ISIN US45782C1027
Net Expense Ratio 0.80 %
Fund Inception Date 9 April 2015
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Factor & Thematic
Asset Class Equities (Stocks)
Index Linked Passive
Index Name IBD 50 Index
Index Provider IBD
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Growth
Continent North America
Key Statistics
Return As of Date 23 September 2021
Asset Under Management 282.50 Million (USD)
1 Month Total Return 11.96 %
Year To Date Return 27.50 %
1 Year Total Return 46.65 %
3 Year Annualized Total Return 12.08 %
NAV 52.3155
Share Outstanding 5,400,000
Top 10 Holdings (23 September 2021)
Constituent Name Constituent Ticker Constituent Type Weighting
INMODE LTD INMD EQUI 0.0387000000
ATKORE INC ATKR EQUI 0.0374000000
DYNAVAX TECHNOLOGIES CORP DVAX EQUI 0.0364000000
CELSIUS HOLDINGS INC CELH EQUI 0.0363000000
UPSTART HOLDINGS INC UPST EQUI 0.0350000000
ASANA INC - CL A ASAN EQUI 0.0347000000
SHOCKWAVE MEDICAL INC SWAV EQUI 0.0343000000
MODERNA INC MRNA EQUI 0.0337000000
LIGHTSPEED COMMERCE INC LSPD EQUI 0.0336000000
TASKUS INC-A TASK EQUI 0.0323000000